121 related articles for article (PubMed ID: 15293458)
1. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
[TBL] [Abstract][Full Text] [Related]
2. [Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis].
Sun ML; Xie WH; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):253-6, 263. PubMed ID: 21776848
[TBL] [Abstract][Full Text] [Related]
3. [Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Sun ML; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):257-60. PubMed ID: 20635652
[TBL] [Abstract][Full Text] [Related]
4. [Clinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinoma].
Yang K; Wen Y; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):447-50. PubMed ID: 14732978
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
Ho YC; Tai KW; Chang YC
Oral Dis; 2007 Jan; 13(1):40-4. PubMed ID: 17241428
[TBL] [Abstract][Full Text] [Related]
6. [The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer].
Yang K; Wen Y; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):477-80. PubMed ID: 14732987
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of cucurbitacinBE polylactic acid nano-particles for targeting cervical lymph nodes].
Yang K; Wen Y; Li L; Wang C; Hou S; Li C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):347-50. PubMed ID: 12539678
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.
Li B; Zheng YB; Li DD; Zhen YS
J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Dai Y; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in KB cells by pingyangmycin.
Tai KW; Chou MY; Hu CC; Yang JJ; Chang YC
Oral Oncol; 2000 Mar; 36(2):242-7. PubMed ID: 10745179
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effect of pingyangmycin on cultured KB cells.
Tai KW; Chang YC; Chou LS; Chou MY
Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy with higher or lower dose of teniposide combined with cisplatin and pingyangmycin for oral squamous cell carcinoma].
Chen WT; Guo W; Xu Q; Pan HY; Ye DX; Qiu WL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):218-20. PubMed ID: 15196390
[TBL] [Abstract][Full Text] [Related]
14. Metastases following biopsy of oral carcinoma in hamsters and the role of local prebiopsy bleomycin.
Rallis G; Mourouzis C; Papakosta V; Donta I; Perrea D; Patsouris E; Vairaktaris E
Anticancer Res; 2008; 28(4B):2253-7. PubMed ID: 18751403
[TBL] [Abstract][Full Text] [Related]
15. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels.
Gao Z; Ding P; Zhang L; Shi J; Yuan S; Wei J; Chen D
Int J Pharm; 2007 Jan; 328(1):57-64. PubMed ID: 16939703
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-cancer efficacy on lymph node metastasis using peplomycin adsorbed on small activated carbon particles.
Ito M; Hagiwara A; Iwamoto A; Shimotsuma M; Yoneyama C; Sasabe T; Takahashi T
Anticancer Drug Des; 1991 Jul; 6(3):169-77. PubMed ID: 1714736
[TBL] [Abstract][Full Text] [Related]
17. [Effect of antibody-targeted chemotherapy with pingyangmycin on prostate cancer cells in vitro].
Chen WZ; Zhang Y; Liang CS; Xie Y; Wen QQ; Gao X
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):406-8. PubMed ID: 18359702
[TBL] [Abstract][Full Text] [Related]
18. [Embolization and degradation of arteries in vivo by pingyangmycin albumin microspheres].
Wang LL; Gao QH; Zheng GJ; Wang XY; Zhou L; Wang CM; Wen YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):279-83. PubMed ID: 19462907
[TBL] [Abstract][Full Text] [Related]
19. Pingyangmycin as a 99mTc carrier in tumor localization.
Huang T; Zhang Y; Wang J; Huang J; Liu D; Mong S
Nucl Med Biol; 1995 May; 22(4):537-42. PubMed ID: 7550032
[TBL] [Abstract][Full Text] [Related]
20. [Visualising lymph nodes by aclarubicin bound to activated carbon particles in breast cancer surgery].
Imanishi T; Hagiwara A; Sawai K; Yamaguchi T; Sakakura C; Shirasu M; Ohgaki M; Yamasaki J; Togawa T; Takahashi T
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1796-8. PubMed ID: 9382535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
